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A type of chromosome-free cell called SimCells (simple cells) has
been generated from Escherichia coli, Pseudomonas putida, and
Ralstonia eutropha. The removal of the native chromosomes of
these bacteria was achieved by double-stranded breaks made by
heterologous I-CeuI endonuclease and the degradation activity of
endogenous nucleases. We have shown that the cellular machin-
ery remained functional in these chromosome-free SimCells and
was able to process various genetic circuits. This includes the gly-
colysis pathway (composed of 10 genes) and inducible genetic
circuits. It was found that the glycolysis pathway significantly ex-
tended longevity of SimCells due to its ability to regenerate ATP
and NADH/NADPH. The SimCells were able to continuously ex-
press synthetic genetic circuits for 10 d after chromosome removal.
As a proof of principle, we demonstrated that SimCells can be used
as a safe agent (as they cannot replicate) for bacterial therapy.
SimCells were used to synthesize catechol (a potent anticancer
drug) from salicylic acid to inhibit lung, brain, and soft-tissue can-
cer cells. SimCells represent a simplified synthetic biology chassis
that can be programmed to manufacture and deliver products
safely without interference from the host genome.
synthetic biology | SimCells | minimal genome | bacterial therapy | cancer
The aim of synthetic biology is to engineer organisms to per-form researcher-designed functions in a safe, reliable, and
robust manner, while the objective of living organisms is to sur-
vive, which is facilitated by adaptation, evolution, and reproduc-
tion. This inherent conflict will jeopardize the performance of
synthetic genetic circuits due to the unwieldy complexity and var-
iability of cells (1), unpredictable gene expression, and interference
from native gene networks (2, 3), as well as defensive disruption
from transposable elements universally present in most organisms
(4). The generation of chromosome-free cells (simple cells or
SimCells) addresses this issue as without the interference of native
gene networks, SimCells should express synthetic genetic circuits
in a more predictable manner (5–8).
As SimCells are reprogrammable chassis cells that exist in a
boundary state between life and nonlife, SimCells could not only
provide insights into the minimal requirements of life but also
expand the applicability of bacterial agents to sensitive envi-
ronments. For example, one application of interest for SimCells
highlighted in this study is bacterial cancer therapy (9). As it is
known that some bacteria preferentially associate with tumors
(10), synthetic biology tools and concepts can be used to further
engineer bacteria to sense, target, and deliver anticancer com-
pounds locally to tumors (11–14). SimCells offer an additional
advantage as a therapeutic agent as they cannot replicate due to
the lack of chromosomal DNA.
In this study, we demonstrated that these chromosome-free
SimCells can be readily generated from a variety of bacteria such
as Escherichia coli, Pseudomonas putida, and Ralstonia eutropha
by inducible chromosomal degradation. Native chromosomes
were removed by I-CeuI endonuclease-mediated double-stranded
breaks (DSBs) and endogenous nucleases (15). The cellular ma-
chinery which remained in the chromosome-free SimCells was
able to process various designed genetic circuits and synthesize
proteins. It was found that a basal-level expression of the glycolysis
pathway significantly extended the functionality of the transcrip-
tion and translation apparatus and maintained enzymatic activity
(e.g., salicylate hydroxylase) in SimCells by regenerating ATP and
NADH. As a proof of principle, we demonstrated that SimCells
can serve as a safe bacterial therapy agent, converting salicylic acid
(SA) into catechol, which was cytotoxic against several malignant
cancer cell lines that have low patient survival rates: adenocarci-
noma (lung cancer) (16), glioblastoma (brain cancer) (17), and
rhabdomyosarcoma (soft-tissue cancer) (18). Hence, SimCells not
only have vast potential in elucidating the minimal requirements
for life but can also be utilized as biocatalysts, biosensors, and
more in sensitive environments.
Results
SimCell Generation by Degradation of the Native Chromosome.
SimCells were generated by making several DSBs on the chro-
mosome, which led to chromosomal DNA degradation facilitated
Significance
We constructed simple cells (SimCells) whose native chromo-
somes were removed and replaced by synthetic genetic cir-
cuits. The chromosome-free SimCells can process designed DNA
and express target genes for an extended period of time. The
strategy of SimCell generation is applicable to most bacteria,
creating a universal platform for reprogramming bacteria. We
demonstrated that SimCells can be designed as safe agents for
bacterial therapy through synthesis and delivery of a potent
anticancer drug against a variety of cancer cell lines. This
showed that the nonreplicating and programmable property of
SimCells is advantageous for applications in sensitive envi-
ronments. The results of this work will both improve our un-
derstanding of natural living systems and simultaneously lay
the foundations for future advances in synthetic biology.
Author contributions: W.E.H. designed research; C.F., P.A.D., and R.H. performed re-
search; C.M.D., M.G.S., K.L., H.E.T., I.P.T., H.Y., Z.C., F.S., and C.N.H. contributed new
reagents/analytic tools; C.F., H.Z., C.M.D., M.G.S., K.L., A.Y., and W.E.H. analyzed data;
and C.F. and W.E.H. wrote the paper.
Competing interest statement: C.F., I.P.T., H.Y., Z.C., and W.E.H. have filed a provisional
patent application with the UK Patent Office related to this work.
This article is a PNAS Direct Submission.
This open access article is distributed under Creative Commons Attribution License 4.0
(CC BY).
Data deposition: The proteomics data are available on MassIVE with DOI 10.25345/
C5HD3F.
1To whom correspondence may be addressed. Email: wei.huang@eng.ox.ac.uk.
This article contains supporting information online at https://www.pnas.org/lookup/suppl/
doi:10.1073/pnas.1918859117/-/DCSupplemental.
First published March 6, 2020.
6752–6761 | PNAS | March 24, 2020 | vol. 117 | no. 12 www.pnas.org/cgi/doi/10.1073/pnas.1918859117
D
ow
nl
oa
de
d 
by
 g
ue
st
 o
n 
Ap
ril
 2
1,
 2
02
0 
by RecBCD helicase-nuclease and other endogenous nucleases
(15, 19, 20). DSBs were made via I-CeuI endonuclease, which
recognizes a specific 26-base pair sequence (5′-TAACTATAAC-
GGTCCTAAGGTAGCGA-3′) (21). This I-CeuI recognition se-
quence is naturally present in most bacterial genomes as it is
encoded within the conserved rrl gene of 23S rRNA (22). Thus,
depending on the copy number of 23S rRNA, I-CeuI endonucle-
ase has multiple recognition sites in the genomes of bacteria
(seven, six, and three sites in E. coli, P. putida, and R. eutropha,
respectively). This particular endonuclease was therefore a stra-
tegic choice because it enables a straightforward conversion of
most bacteria to SimCells. In addition, there is a very low proba-
bility (1 in 4.5 × 1015 bp sequences) that this 26-bp recognition se-
quence would appear in designed genetic circuits or minigenomes.
The creation of multiple DSBs is lethal to bacterial cells;
therefore, a strain containing I-CeuI cannot survive unless the
expression of I-CeuI is under very tight control. To choose the
optimal genetic circuit to express I-CeuI endonuclease for
chromosomal degradation, we screened a variety of tight regu-
latory systems (23, 24). The TetR family repressors TetR (pJKR-
H-TetR) and EilR (pRH121) (SI Appendix, Table S1) showed
very low basal expression when not induced but a high level of
expression when induced (23, 24). Thus, the I-CeuI gene was
placed under control of the anhydrotetracycline (ATc) and
crystal violet inducible TetR and EilR genetic circuits (SI Ap-
pendix, Figs. S1B and S2A and Table S1). The TetR system was
used in E. coli, and the EilR system was used in P. putida and
R. eutropha. When induced, I-CeuI made several DSBs in the
chromosomes of these organisms. A DSB is usually repaired
through homologous recombination with RecBCD and RecA
(25). However, since I-CeuI simultaneously produced several
unrepairable DSBs in the chromosome, it resulted in instability
and subsequent DNA breakdown by RecBCD and other nucle-
ases (19, 26–29). Based on the gradual loss of DAPI (Movies S1–
S3), chromosomes were shown to be removed after the chro-
mosome cutting activity of multiple DSBs and degradation by
nucleases (SI Appendix, Fig. S3). These chromosome-free cells
have now become simple cells or SimCells. A control strain that
lacked I-CeuI expression preserved the chromosome and did not
lose the blue fluorescence of DAPI (Movie S1B and SI Appendix,
Fig. S3) when observed for the same amount of time. The deg-
radation rates of the E. coli, P. putida, and R. eutropha chro-
mosomes were 200, 225, and 147 bp/s, respectively (SI Appendix,
Table S3). These rates were likely dependent on the number of
I-CeuI restriction sites, the size of the genome, and the number of
RecBCD molecules. Moreover, the successful degradation of the
chromosomes of E. coli, P. putida, and R. eutropha validates the
SimCell generation method as being a universal approach for
the production of chromosome-free cells from different bacterial
genera.
Functionality and Longevity Design for Characterization of SimCells.
The constructed SimCell needed to possess and demonstrate
several properties in order to validate its identity and function-
ality. Fig. 1A is an overview of the elements contained in a parent
E. coli cell before it becomes a SimCell, and Fig. 1B details the
attributes of each plasmid. The functions of the three plasmids
are controllable chromosome cutting (pJKR-HTetR-ICeuI),
ATP and NADH regeneration (pSEVA224-GB3), and cargo
expression (pJKR-OmphR-X) (SI Appendix, Table S1). To
confirm that the cell is chromosome-free, the parent strain
contains a chromosomal GFP marker controlled by an arabinose
regulation system. Parent cells that still have their chromosomes
will produce GFP, while the chromosome-free SimCells will be
unable to produce GFP when induced with arabinose.
A gene cluster encoding the entire glycolysis pathway, which
produces ATP and NADH, was included in the SimCells. The
gene cluster contains 10 genes under control of the IPTG-
inducible promoter Ptrc (30) on the plasmid pSEVA224-GB3 (SI
Appendix, Table S1 and Fig. S1C). The cargo expression plasmid
inside the SimCells differed depending on the proof-of-concept
experiment being conducted, but they all were controlled by a
tightly regulated MphR system encoded by pJKR-O-mphR to
produce some product in response to erythromycin induction.
The cargo carried on pJKR-OmphR-X was either mCherry (SI
Appendix, Fig. S1D), an unstable variant of mCherry (mCherry-
ASV) (SI Appendix, Fig. S1F), or the ilux operon (SI Appendix,
Fig. S1E). The former established functionality and the latter
two elucidated the longevity of SimCells.
The three plasmids (pJKR-HTetR-ICeuI for chromosomal
degradation, pSEVA224-GB3 for energy regeneration, and
pJKR-OmphR-X for protein production) were transferred to
the parent E. coli strain BW31003 before I-CeuI was induced to
generate SimCells. The strains without I-CeuI and/or the glycolysis
pathway, containing only the vector backbones (pSEVA224 and
pJKR-H-TetR), acted as the control groups in this study.
Quantification of SimCell Generation Efficiency. The efficiency and
efficacy of I-CeuI endonuclease in generating SimCells was
characterized using cell viability and flow cytometry to estimate
the proportion of SimCells in a mixed population after I-CeuI
endonuclease activity. As SimCells no longer contain the chro-
mosome and thus cannot replicate, cultures were plated to see
how many parent E. coli cells remained in the population by
counting the colony forming units (CFU) (Table 1). The strains
with the I-CeuI gene had CFU/mL about two magnitudes lower
compared to its corresponding control strain (no I-CeuI). This
indicated that I-CeuI endonuclease indeed had an effect on cell
viability as the chromosomes would have been degraded (Movies
S1A, S2, and S3). Based on these results, induced I-CeuI cultures
Fig. 1. The main features for the constructed SimCell characterized in this
study. (A) To distinguish SimCells from normal cells, a strain with chromo-
somal expression of GFP controlled by the arabinose operon was used to
indicate the integrity of the chromosome. Three additional plasmids are
used to degrade the chromosome, reintroduce glycolysis, and produce pro-
tein (mCherry, mCherry-ASV, or the ilux operon). (B) For SimCell generation
(chromosome degradation), pJKR-HTetR-ICeuI (high copy number plasmid)
was constructed to put I-CeuI endonuclease production under control of the
TetR regulation system which is inducible by ATc. To improve longevity, ATP
and NADH generation was supplemented to cells via the glycolysis pathway
carried by pSEVA224-GB3 (low copy number plasmid). The glycolysis pathway
genes are controlled by the lac system inducible by IPTG. However, the I-CeuI
and the glycolysis genes were not induced for the majority of experiments
presented in this work. Finally, the strain contains variants of pJKR-O-mphR-X
(medium copy number plasmid) which produces either mCherry, mCherry-ASV,
or luminescence depending on the application. This plasmid utilizes the MphR
regulation system which is inducible by erythromycin.
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still contained about 1.4 and 3.8% parent cells without and with
the glycolysis plasmid, respectively.
Flow cytometry was used to quantify chromosome-free SimCells
by using the arabinose-inducible gfp circuit on the chromosome of
parent cells. Fluorescence microscopy showed that both the AraC
and MphR regulation systems were tight, and basal expression was
not observed from uninduced strains. When induced, there was
clear and obvious expression of GFP and mCherry (Fig. 2A).
Control cell cultures (no I-CeuI) with and without arabinose or
erythromycin induction were mixed to define GFP or mCherry
expression boundaries when there were not distinct populations
(Fig. 2B). Based on flow cytometry analysis, the majority of the
I-CeuI–induced culture were SimCells: 91.32% of the population
in strains without glycolysis and 94.36% with glycolysis (Fig. 2 C
and D). Assuming the rest were parent cells (8.68 and 5.64%),
estimations of the parent cell population remaining in I-CeuI–in-
duced cultures were slightly higher with flow cytometry versus cell
plating experiments. This discrepancy could be due to ambiguity of
GFP expression as determined by flow cytometry.
It was unexpected to observe a substantial population of
parent cells remaining in an induced I-CeuI population as the
seven DSBs made on the E. coli chromosome should have been
very destructive. However, the bacteria were still able to deploy
their arsenal of survival strategies to deactivate the I-CeuI gene
in later generations, thereby restoring growth fitness and ac-
counting for the existence of parent cells; this phenomenon is
explored further in another study (4). It also reinforces the idea
that there is a need for a stable and robust chassis cell for syn-
thetic biology. By lacking a genome, SimCells are a step forward
in addressing this need as they avoid the possibility of genetic
drift and evolvability (31, 32).
Expression of Designed Genetic Circuits by SimCells. Once it was
established that chromosome-free SimCells could be generated,
we sought to prove our premise that plasmid DNA or mini-
genomes could prompt SimCells to express designed genetic
circuits. Flow cytometry was also used to determine the pop-
ulation of SimCells that were expressing mCherry (pJKR-O-
mphR). As done previously, a control strain (no I-CeuI) was
either not induced or induced for mCherry expression to define
expression boundaries when distinct populations were not ob-
served (Fig. 2B). Using the previously established GFP expres-
sion gates, the SimCell population (no GFP) was isolated. Of the
SimCell population, it was estimated only 13.18% of those
without glycolysis were producing mCherry, but this proportion
considerably increased to 56.20% with the reintroduction of
glycolysis (ATP and NADH generation) (Fig. 2 C and D). A
proportion of SimCells could not produce mCherry. The resto-
ration of just one metabolic pathway (glycolysis) was likely not
sufficient to obtain a fully functional SimCell population. How-
ever, this large improvement in SimCell performance shows that it
is important to reintroduce metabolic pathways in minimal cells to
provide ATP and NADH for cellular processes to function.
Fig. 2 C and D also show fluorescence microscopy images of
strains with I-CeuI induced for GFP and mCherry expression.
Cells that are expressing GFP still have an intact chromosome
so, thus, are not SimCells. Cells that are only fluorescing red are
SimCells that are producing mCherry. The results from flow
Table 1. CFU/mL of I-CeuI+ versus I-CeuI- cultures
Strain CFU/mL
ICeuI+ glycolysis− 2.67 × 106
ICeuI− glycolysis− 1.87 × 108
ICeuI+ glycolysis+ 5.58 × 106
ICeuI− glycolysis+ 1.46 × 108
Overnight cultures of strains with or without the I-CeuI gene (pJKR-
HTetR-ICeuI) and with or without the glycolysis pathway (pSEVA224-GB3)
were plated out to count the CFU/mL and quantify the number of normal
cells remaining in the population. The dilutions that were plated out were
normalized to have the same OD600. Strains with I-CeuI had about 100x
fewer colonies than those without I-CeuI, demonstrating the adverse effect
of I-CeuI on cell viability due to chromosomal degradation.
Fig. 2. FL1 (GFP) and FL3 (mCherry) channel histograms of flow cytometry analyses and corresponding microscopy images. (A) Fluorescence microscopy
images of a control strain (no I-CeuI) to show integrity of the GFP and mCherry biosensors. The parent strain (I-CeuI-) was (Left) not induced, (Center) induced
for GFP expression, or (Right) induced for mCherry expression. (B) FL1 (GFP) and FL3 (mCherry) channel histograms had distinct populations which were used
to define no expression and GFP expression (SimCell identity gates) or mCherry expression (protein production) when two populations were not obvious in
the experimental groups. (C) The I-CeuI+ strain without the glycolysis pathway (pSEVA224-GB3) contained a mixed population of SimCells and normal cells.
Based on the two somewhat distinct populations, about 91.32% of cells are SimCells (GFP-). Of the SimCell population, only 13.18% produced mCherry. (D) In
the I-CeuI+ strain with the glycolysis pathway (pSEVA224-GB3), about 94.36% of cells are SimCells (GFP-), a slightly higher proportion compared to the strain
without glycolysis. Of the SimCell population, 56.20% produced mCherry, a large improvement compared to the strain without glycolysis.
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cytometry and fluorescent microscopy images are consistent,
indicating that SimCells with pSEVA224-GB3 (encoding gly-
colysis pathway mediated ATP and NADH generation) enhances
functionality (Figs. 2 and 3). There are more SimCells producing
mCherry as glycolysis was able to generate ATP and NADH.
These images (Fig. 2 C and D) also show that flow cytometry can
be used to estimate the proportion of SimCell production and
to quantify the efficiency of an inducible genetic circuit
in SimCells.
To confirm that these red-only cells are nonreplicating Sim-
Cells producing protein, cells were fixed in LB agar with the
inducers arabinose and erythromycin and allowed to grow
overnight. The control strain (no I-CeuI) (SI Appendix, Fig. S4A)
grew colonies that dominated the agar, and there was expression of
both GFP and mCherry. In contrast, a strain with I-CeuI (SI Ap-
pendix, Fig. S4B) contained SimCells which have lost the ability
to replicate. While there were a few parent cells that avoided
chromosomal degradation and replicated to form colonies that
expressed GFP and mCherry, there were more individual SimCells
that were only expressing mCherry. This confirmed that cells which
were not expressing GFP were chromosome-free, nonreplicating
cells. Movie S4 shows the progression of SimCell generation and
subsequent protein production. Cells containing chromosomal
DNA were stained with DAPI and fixed in PBS agar containing
I-CeuI endonuclease, GFP, and mCherry inducers. After induc-
tion of I-CeuI expression, the degradation of the chromosome was
triggered. This is evidenced by the loss of blue fluorescence as the
chromosomal DNA degraded into nucleotides. The newly formed
SimCell then started producing red fluorescence (mCherry).
These observations demonstrated that SimCells were indeed
producing mCherry and that mCherry was not an artifact from
synthesis performed by the parent cell.
In summary, these results show that the chromosome-free
SimCells could still produce protein when instructed by a genetic
circuit, and this activity can be enhanced by reintroducing the
glycolysis pathway to generate ATP and NADH.
Purification of SimCells. As shown by the flow cytometry and cell
plating experiments, SimCell generation was not fully efficient
after I-CeuI endonuclease activity. In order to elucidate distinct
features and characteristics of SimCells, they needed to be pu-
rified from parent cells. Previous methods of purification were
attempted or considered (FACS, density or charge-based cell
sorting, magnetic nanoparticles, etc.); however, they were either
uneconomical or ineffective. D-cycloserine has previously been
used to purify minimal cell cultures (33), so it was evaluated for
its efficacy in killing actively dividing parent cells that remained in
I-CeuI+ cultures. Table 2 shows the CFU/mL of strains over time
after application of D-cycloserine at time 0 and 1.5 h. In the
presence of D-cycloserine, actively dividing cells will not sur-
vive, because cell wall biosynthesis is inhibited by the drug. This
means the cell wall cannot sustain increasing cellular volume,
resulting in osmotic lysis (34–36). Although D-cycloserine was
unable to kill all of the cells in the control strain, in an
I-CeuI+ strain parent cells were effectively eliminated, yielding
a pure SimCell culture. This can also be seen in Fig. 3 in which
no cells are expressing GFP, indicating that they lack a chro-
mosome and are thus SimCells. As SimCells were purified first
and then induced for mCherry expression, these results are also
evidence that SimCells produced protein and it was not residual
Fig. 3. I-CeuI+ cultures were treated with the drug D-cycloserine to kill parent cells to yield a pure SimCell culture. (A) SimCell culture without glycolysis (Top)
not induced and (Bottom) induced for GFP and mCherry production. (B) SimCell culture with glycolysis (Top) not induced and (Bottom) induced for GFP and
mCherry production. No cells fluoresced green, which meant D-cycloserine was effective in killing parent cells and producing a pure SimCell culture. A higher
proportion of SimCells (no GFP expression) expressed mCherry when supplemented with glycolysis (pSEVA224-GB3).
Fan et al. PNAS | March 24, 2020 | vol. 117 | no. 12 | 6755
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expression from parent cells. These images also highlight the
benefit of glycolysis as it allowed more SimCells to produce
mCherry (Fig. 3).
Further optimization of D-cycloserine concentration ensured
pure SimCell populations in the following experiments and ex-
cluded the contribution made by any remaining parent cells in
SimCell populations. After a screen of D-cycloserine concen-
trations, 25 μg/mL was determined to be the point where parent
cells were killed in the culture evidenced by little to no increase
in OD600 but also permitted protein production or other activ-
ities in SimCells. By using D-cycloserine which targets active,
parent cells, we were able to distinguish activity from SimCells
on a larger, culture-level scale for further characterization.
Shelf Life of SimCells. In order to establish the applicability of
SimCells, it was necessary to characterize how long they could be
maintained in storage. SimCells were purified using D-cycloserine
from strains containing the mCherry expression plasmid and with
or without the pSEVA224-GB3 plasmid encoding the glycolysis
pathway. Aliquots of purified SimCell culture were then stored at
either 4 or −80 °C with glycerol. At 1 wk, 1 mo, and 5 mo after
storage, SimCells were induced for mCherry production. SI Ap-
pendix, Fig. S5, shows that SimCells can be preserved for at least
5 mo. As expected, more SimCells can produce mCherry with the
glycolysis pathway than those without, although the number of
SimCells that can produce mCherry decreased after they were
stored. In general, it seemed that SimCells preserved at 4 °C
performed better than those stored at −80 °C in terms of in-
ducible mCherry expression from pJKR-O-mphR. There is some
evidence that suggests storage at subzero temperatures and
subsequent thawing can cause metabolic injury to cells (37) and
affect growth kinetics (38). In the case of SimCells, it is likely
that at 4 °C, cellular processes were quiescent rather than shut
down at −80 °C, and thus, cells were more readily reactivated
and recovered.
Longevity of SimCells.We considered longevity as the functionality
of cell transcription and translation machinery. To characterize
the longevity of energy reserves, the production of biolumines-
cence by purified SimCells via the ilux operon was used as an
indicator. This is because ATP and/or NADH are needed to
facilitate the conversion of FMNH2 and -CHO to FMN and
-COOH by enzymes (fatty acid reductase and flavin oxido-
reductase) in order for luciferase (luxAB) to produce bio-
luminescence (39). Thus, the ilux operon was integrated into the
pJKR-O-mphR plasmid (SI Appendix, Fig. S1E) and introduced
to SimCells. Bioluminescence was induced, and its production
was tracked in SimCells over time (Fig. 4A). Bioluminescence
production reached the highest levels around day 3 but de-
creased thereafter. SimCells seemed be significantly starved of
ATP/NADH around day 10, and only background levels of lu-
minescence were detected by day 14. Interestingly, the read-
dition of the glycolysis pathway made less of an impact on
SimCell performance than anticipated. It could be that the en-
zymes needed for glycolysis remained in suitable concentrations
before the SimCells were generated. Therefore, even without the
glycolysis plasmid, SimCells could still produce comparable levels
of luminescence. It is likely that with the glycolysis plasmid, the
higher than average concentration of enzymes allowed an initial
burst of increased activity (as seen from day 1 to 3), but this benefit
to the cells was eventually lost as the cost of making the 10 proteins
in the glycolysis pathway conferred a significant energy burden.
This pattern of behavior was also described by our mathematical
model (SI Appendix, Fig. S7D).
Transcription and translation take up a large part of the cell’s
energy budget (40) and are important indicators of cellular
machinery and protein processes (synthesis, regulation, and
degradation), so it is important to evaluate how long the
SimCell is able to maintain these processes. To estimate the
longevity of the transcription and translation apparatus, as well
as the function of degradation enzymes in SimCells, an unstable
version of mCherry-ASV was created by fusing a ssrA protease tag
(VSAAYNEDNAAPR) (41) to the mCherry gene, which pos-
sessed a shorter half-life time (SI Appendix, Fig. S6 and Movie S5).
The mCherry-ASV reporter gene served as an indication that the
major players in protein metabolism such as RNA polymerases, ri-
bosomes, and proteases were still active. Fig. 4B shows mCherry-ASV
expression over time by purified SimCells with or without glycolysis.
Levels of fluorescence reached their highest around day 5 and started
to decrease around day 14, and only background levels of fluores-
cence were detected after 28 d. The benefit of reintroducing glycolysis
is not obvious from these results. The protein metabolism machinery
seemingly lasted longer than the ATP available in the cell (Fig. 4A),
but we must also consider the fact that the ClpXP and ClpAP
proteases which degrade the ssrA-tagged mCherry-ASV (42) re-
quire ATP to function (43). Therefore, the point at which fluo-
rescence levels no longer increase (day 5 to 10) is likely when the
protein machinery started to lose functionality.
In summary, SimCells have a longevity of about 10 d in terms
of access to an energy source and functionality of cellular ma-
chinery for the expression of genetic circuits and facilitation of
metabolic processes. Therefore, SimCells could be robust
enough to remain active and functional for most applications in
medicine or biomanufacturing.
The Trade-Off Between Energy Generation and the Cost of Gene
Expression. The glycolysis pathway generates valuable resources
such as ATP and NADH, but the expression of glycolytic genes is
energetically costly (SI Appendix, Fig. S7 A and B). Hence, there
is a delicate balance between energy generation and gene ex-
pression. A mathematical model was developed to simulate this
trade-off (Eqs. 1–4 and SI Appendix). The 10 genes that encode
the glycolysis pathway are controlled by a Ptrc promoter and the
LacI repressor, which has leaky expression due to the poor
binding kinetics of LacI (SI Appendix, Fig. S9). The over-
expression of glycolysis by IPTG induction in SimCells was so
costly and energy-consuming that SimCells were unable to allo-
cate resources to express other genes such as the ilux operon or
mCherry-ASV (SI Appendix, Figs. S7 and S8). In contrast, leaky
expression or IPTG induction of glycolytic genes in parent cells
Table 2. Purification of SimCells with D-cycloserine
Time (h) ICeuI−glycolysis− ICeuI+ glycolysis− ICeuI− glycolysis+ ICeuI+ glycolysis+
0 1.8 × 109 3.5 × 105 1.0 × 109 3.08 × 105
1.5 1.1 × 109 4.1 × 103 6.9 × 108 2.7 × 103
5 1.3 × 107 7.2 × 102 4 × 107 7.5 × 102
24 1.6 × 107 0 8.3 × 104 0
Cultures were treated with 200 μg/mL D-cycloserine at time 0 and 1.5 h to kill normal cells to yield a pure
SimCell culture. Plate counts over time estimated the CFU/mL and efficacy of the drug. Several dilutions were
plated to ensure normal cells were killed. D-cycloserine effectively killed normal cells in strains with I-CeuI,
indicating that it was an effective drug.
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can assist bioluminescence and mCherry production in SimCells
in the first 3 d. However, this benefit is lost after 3 d due to the
cost of making glycolytic proteins, and the performance is similar
to SimCells that did not contain the glycolysis pathway (SI Ap-
pendix, Figs. S7 and S8). The mathematical simulation also
conceptually supports this observation (SI Appendix, Fig. S7 D
and F).
Proteomics Revealed Changes in Global Regulation of Proteins in
SimCells. We knew that the consequences of I-CeuI endonucle-
ase activity may not be limited to chromosomal degradation.
Hence, proteomics analysis was done in a related study (4) to
investigate the changes in protein abundances after I-CeuI en-
donuclease activity. The E. coli DH5α strain with no vector or
with an empty vector backbone were used as controls, and DH5α
with the I-CeuI gene was designated as the experimental, Sim-
Cell condition. It was found that indeed the protein expression
profile of the I-CeuI+ culture was almost opposite to that of the
control groups (SI Appendix, Fig. S10A).
When we dissected the results of specific cellular processes,
the same trend of distinct I-CeuI protein expression profiles was
observed. In terms of energy and metabolism (SI Appendix, Fig.
S10B), a SimCell-induced population up- or down-regulated
certain genes to maximize cellular resources to make ATP
(energy currency) during a state of energy starvation. Sections of
the glycolysis and pentose phosphate pathways that generated
ATP and NADH were up-regulated, while sections that consumed
ATP were down-regulated (Fig. 5). It is also found that the TCA
cycle was largely shut down. This enhanced carbon metabolic re-
sponse to energy starvation was also observed in other studies
where the cell experienced DNA damage and launched a stress
response (44). With the deletion of the chromosome, we reduced
the functional space of the cell’s metabolic network (45), which
resulted in a less complex interactome (the whole set of mo-
lecular interactions) and streamlining of the cellular processes
in SimCells.
The most obvious phenotypic effect caused by I-CeuI is the
presence of longer cells, indicating a change in the normal pro-
cess of cell division (SI Appendix, Figs. S3 and S5). A typical
E. coli is about 2 μm in length, but strains with I-CeuI have
produced cells that can be 20 μm or longer (Figs. 2 and 3 and SI
Appendix, Fig. S4B). These filamentous cells have been observed
before in cells that have launched an SOS response due to DNA
damage (SI Appendix, Fig. S10D) as essential genes for cell di-
vision are often shut down by SOS genes (46). However, the SOS
response is subsequently silenced after attempted DNA repair
(47, 48). Other studies have observed that when FtsZ is down-
regulated or mutated in parent cells, cells can reach up to 750 μm
in length and are still metabolically competent and will synthe-
size DNA (49). This preservation of functionality is also sup-
ported by our results as the longer SimCells could still produce
mCherry (Figs. 2 and 3 and SI Appendix, Fig. S4B).
The degradation of the chromosome caused by DSBs made by
I-CeuI endonuclease launched a dramatic cellular response that
affected processes such as cell division, protein metabolism, and
Fig. 4. Longevity of the cellular machinery within SimCells (protein synthesis, regulation, and degradation) was elucidated by indirectly tracking the cellular
availability of ATP/NADH. (A) SimCells could produce luminescence for about 10 d, indicating they had sufficient energy currency to sustain functionality for a
significant amount of time. The strain with the glycolysis pathway had a significant energy advantage over the strain without glycolysis in the early days. However,
this difference in luminescence production leveled off after day 5. Unpaired (independent) t tests were performed: *P < 0.005, **P < 0.001. (B) Fluorescence
detected from unstable mCherry stopped increasing after 10 d, which is likely the point where transcription and translation did not have enough energy to be
operational. This corresponds to the availability of ATP as suggested by luminescence production (A). SimCells had detectable levels of unstable mCherry for a long
time (28 d) because the activity of proteases is ATP-dependent. Unpaired (independent) t tests were performed: *P < 0.001. Data show means ± SE, n = 4.
Fig. 5. A graphical summary of changes in energy and metabolism in
SimCells (I-CeuI+ strains). Elements in red indicate up-regulation of proteins,
while elements in blue indicate down-regulation of proteins. Cells favored
sections of the glycolysis and pentose phosphate pathway that produced
ATP/NADH, while the sections that consumed ATP were down-regulated.
The TCA cycle was largely shut down. Fermentation and respiration regen-
erated NAD+ to be fed back to the glycolysis pathway. The complexes that
were up-regulated to generate the proton gradient are shown (other
complexes were down-regulated). The resulting proton gradient should
drive ATP synthase to produce ATP for the energy-starved cell.
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ATP generation. Proteomics analysis indicated which processes
were prioritized, kept on standby, or shut down and which cel-
lular machineries were present in SimCells, providing insight into
the design of genetic circuits or minigenomes.
SimCells as Safe and Anticancer Delivery Agents. Catechol (1,2-
dihydroxybenzene) is a naturally occurring compound in fruits
and vegetables and a moiety of caffeic acid and catechin (tea)
(50). Catechol has previously been shown to have selective cy-
totoxic effects by inducing apoptosis in lung and brain cancer cell
lines (51, 52), but it is not harmful to normal cells (e.g., fibro-
blasts). Taking advantage of the anticancer properties of cate-
chol, SimCells carrying the pSalAR-GFP plasmid were used to
convert SA into catechol (53, 54) and export this product to kill
cancer cells (Fig. 6A and SI Appendix, Fig. S1G).
The plasmid pSalAR-GFP contains a positive autoregulation
genetic circuit, which produces SalA (salicylate hydroxylase) and
SalR when induced by SA (Fig. 6A and SI Appendix, Fig. S1G).
SalR is a transcriptional regulatory protein and a LysR-type
transcriptional regulator (LTTR) family protein that transitions
to its active form in the presence of SA or aspirin and acts as an
activator for its own promoter Psal, effectively forming a positive
feedback loop (55, 56). The salicylate-inducible Psal-SalR regu-
lation system has been optimized in E. coli (55). SA can activate
the Psal promoter within a range of 0.05 to 500 μM and activate
the genetic circuit in under an hour (55, 56). SalA catalyzes the
conversion of SA to catechol by consuming NADH (53, 57). This
plasmid was transferred to E. coli parent cells and SimCells (later
purified) with and without the glycolysis pathway (pSEVA224-
GB3). Liquid chromatography (LC) analysis (Fig. 6B) showed a
dramatic increase in catechol production by parent cells and
SimCells when induced with higher concentrations of SA. This
was due to the positive feedback nature of the genetic circuit.
SimCells with the glycolysis pathway were able to make comparable
amounts of catechol to the parent cell counterparts when induced
with 500 μM SA (Fig. 6B). The significant improvement of cate-
chol production in SimCells containing the glycolysis pathway can
be attributed to the dependency on NADH in salicylate conversion
into catechol (57). It suggests that the glycolysis pathway made a
large contribution to the conversion of SA to catechol. Given that
the SimCell population was 8 × 108 cells per mL, each SimCell
produced about 5 × 10−16 moles of catechol in 24 h from 500 μM
SA. This amount of catechol being produced in the small volume
of a bacterial cell (about 1 μm3) would have had a high local
concentration of catechol, about 500 mM, which subsequently
diffused out of the SimCells (SI Appendix, Fig. S11). If SimCells
were further engineered to target and attach to the surface of
cancer cells, the cytotoxic properties of catechol would be en-
hanced with local delivery.
Screens showed that catechol significantly decreased the via-
bility of A549 (lung), Mo59K (brain), and RD (soft-tissue)
cancer cell lines at concentrations as low as 100 μM but had less
of an adverse effect against normal cells like fibroblasts (Fig.
6C). Additionally, SimCell control, SA (the substrate), and D-
cycloserine (to maintain SimCell purity) did not cause the death
of four cell lines (fibroblasts, A549, Mo59K, and RD) (SI Ap-
pendix, Fig. S12), which means a decrease in cell viability could
be attributed to the cytotoxic effects of catechol. These cell lines
were subsequently incubated with SimCells containing the gly-
colysis pathway and pSalAR-gfp-full plasmids in various SA
concentrations. SimCells induced with 500 μM SA for catechol
production significantly lowered the cell viability and confluency
of all cancer cell lines but did not kill fibroblasts (noncancerous
cells) (Fig. 6D and SI Appendix, Fig. S13). It should be noted that
these results are not clinically significant, and further work has to
be done before SimCells can be realistically applied. However,
the results in this study have demonstrated that SimCells were
able to act as biocatalysts to produce catechol which was cytotoxic
Fig. 6. SimCells as a biocatalyst. (A) Schematic of the genetic circuit in pSalAR-GFP that produces catechol from SA. When SA is present it combines with SalR
to yield an active form, SalR*, which then initiates transcription of salA and salR (positive feedback). SalA or salicylate hydroxylase then converts SA to
catechol in the presence of NADH. There is some basal expression from Psal, so low levels of SalA and SalR are already present without induction. (B)
Quantification of catechol produced by parent cells and SimCells using LC. Moles of catechol produced per cell by strains with pSalAR-GFP or pSalA_Km_xylR
(negative control, defective salA) were quantified after induction with different concentrations of SA. Strains labeled “no glycolysis” or “with glycolysis” have
pSEVA224 or pSEVA224-GB3, respectively. Strains labeled “Parents” or “SimCells” have pJKR-H-TetR or pJKR-HTetR-ICeuI, respectively. More catechol was
produced with higher concentrations of inducer. In SimCells, the addition of the glycolysis pathway dramatically improved catechol production. An unpaired
(independent) t test was performed: *P < 0.001. Data show means ± SE, n = 3. (C) Anticancer effect of catechol. Fibroblasts and cancer cell lines A549, Mo59K,
and RD were treated with different concentrations of catechol (PBS was the control), which resulted in a significant decrease in cell viability of cancer cells. A
paired (dependent) t test was performed for cell viability assays: *P < 0.005, **P < 0.001. Data show means ± SE, n = 6. (D) Anticancer effect of catechol
produced by SimCells. Fibroblasts and A549, Mo59K, and RD cancer cells were incubated with SimCells induced with different concentrations of SA to produce
catechol. There was a significant decrease in cell viability when SimCells were induced to produce the anticancer drug catechol. SimCells induced with 500 μM
SA resulted in the largest decrease in cancer cell viability. A paired t test was performed for cell viability assays: *P < 0.05, **P < 0.005. Data showmeans ± SE, n = 6.
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against cancer cells but did not kill noncancerous cells. SimCells
have some advantages over traditional bacterial therapy in
medicine because they are inducible, functional, and control-
lable (nonreplicating minimal cells).
Discussion
In this work, we constructed and characterized a different type of
minimal cell called SimCells or simple cells, with the intention of
applying it as a chassis for reprogramming microorganisms. We
developed a universal method to generate chromosome-free
SimCells from almost all bacterial genera. These SimCells have
the potential to host a minimal genome as a core genetic oper-
ating system that can be manipulated in a predictive manner and
execute predefined functions (58). Additionally, as SimCells are
unable to replicate due to the absence of the chromosome, this
alleviates some of the biosafety concerns associated with genet-
ically modified microorganisms (59).
SimCells were readily generated by removal of the chromosome
by exploiting the combined activity of I-CeuI endonuclease-
mediated DSBs and RecBCD-mediated DNA degradation
(Movies S1A, S2, and S3). This SimCell generation method is
simple and valuable because it can be applicable to bacteria other
than E. coli (such as P. putida and R. eutropha in this study) as the
I-CeuI recognition sequence is present in 23S rRNA and, thus,
occurs several times in the bacterial genome. Studies usually ob-
serve chromosomal degradation in recA mutants as RecA plays a
vital role in DSB repair (15, 28, 60). However, as we generated
several DSBs the RecA proteins were probably unable to halt
chromosomal degradation by RecBCD.
Unlike protocells that are liposomes or vesicles, the SimCell
retains its original bacterial cell membrane. The bacterial
membrane houses many vital functions: sensing of environmental
signals, generation of ATP via proton gradients created by the
electron transport chain, the import of nutrients into the cell,
and the export of waste out of the cell (61). To maintain the
function and extend the shelf life of SimCells, we have identified
the following key requirements: 1) a system to regenerate ATP and
the electron carrier, e.g., NAD(P)H, thereby ensuring the main-
tenance of energy flux and redox reactions; 2) the synthetic design
of a physically robust cell structure and stable cellular machinery;
3) machinery repair of central dogma components including DNA,
RNA, RNA polymerase, sigma factors, ribosomes, and tRNA; 4) a
supply (including recycling) of essential building blocks, such as 12
precursor metabolites, amino acids, and nucleoside triphosphate
(NTPs); and 5) continuous removal of reaction by-products and
degradation of some RNA and proteins.
Our results support the idea that certain metabolic pathways
and machineries (e.g., transcription and translation) are prefer-
entially up-regulated to ensure cell survival and function, which
provide insights into the design and construction of minimal
cells. We showed that when instructed by plasmid DNA, Sim-
Cells are able to produce protein, and this activity was improved
after the glycolysis pathway was restored in cells, with about 56%
of SimCells being metabolically active. The SimCells in this study
sustained functionality for about 10 d until they expended their
energy currency. Proteorhopsin (PR) is a light-activated proton
pump, which can promote proton motive force and enhance ATP
synthesis in the presence of light. It has been found that E. coli
expressing PR can survive better even in the dark, compared with
E. coli without PR (62). E. coli can assemble a high density of PR
molecules (187,000 per cell) on the membrane, which presumably
act as a scaffold stabilizing the cytoplasmic membrane, maintaining
cellular levels of DNA and RNA and avoiding deterioration of the
cytoplasmic membrane, a likely basis for extended viability (62).
Hence, PRs in SimCells will not only help ATP regeneration
under light but also serve as scaffold to maintain the integrity
of cells and extend the shelf life of SimCells. It would be
valuable to test if shelf life could be improved with alternative
temperatures such as −20 °C and to try different cryoprotec-
tants such as DMSO (dimethyl sulfoxide). Any further design
should include genes encoding for a cellular machinery repairing
system and pathways for the supply of central metabolites. It is
likely that the continuous removal of products and waste could
help maintain the equilibrium of SimCells and significantly extend
the functional time of this artificial system (63).
SimCells could be engineered to specifically target cancer cells
to enhance the efficacy of catechol. For example, expression of
cancer biomarker such as carcinoembryonic antigen (CEA) on
the surface of SimCells (surface display) would enable SimCells
to recognize and bind colon cancer cells (64). This combination
of SimCell binding to cancer cells and local delivery of a high
concentration of catechol (from aspirin/salicylate) should result
in an enhanced killing effect. Additionally, SimCells carrying
different regulation systems, such as the recA regulation system
(activated by γ-radiation therapy for cancer), could be explored
to control the safe release of anticancer drugs generated by
SimCells in order to enhance the anticancer effects.
For real-world applications, it is important to effectively
remove parent cells and obtain highly purified SimCells. SimCells
have much less DNA than parent cells due to the absence of
chromosomes, a potentially useful distinguishing feature. Single-
cell Raman spectra (SCRS) are label-free biochemical profiles of
single cells (65). Preliminary experiments showed that the char-
acteristic DNA bands in SCRS of SimCells were dramatically
lower than that of parent cells (SI Appendix, Fig. S15). Hence, the
Raman bands for DNA (785 and 1,575 cm−1) could be used as the
sorting criteria for the removal of parent cells using Raman acti-
vated cell sorting (RACS) (66). Cells sorted by RACS remain
functional (67, 68).
The chromosome-free SimCell will be a universal platform for
reprogramming bacterial cells and can drive advancements in
cell design and the construction of synthetic cells. SimCells have
the potential to open up new frontiers in synthetic biology: they
can be utilized as minimal cells to study the basic requirements
for life or they can be chassis cells, enabling the development of
new and smart systems for biomanufacturing, healthcare, agriculture,
and environment.
Materials and Methods
Construction of an Endonuclease Expression Plasmid. The strains and plasmids
used in this study are listed in SI Appendix, Table S1. Primers used in this
study are listed in SI Appendix, Table S2. The construction of other plasmids
used in this study is described in SI Appendix.
The I-CeuI endonuclease gene was synthesized by ThermoFisher Ltd
(GeneArt) to yield pGeneArt-ICeuI (SI Appendix, Fig. S1A). In pGeneArt-ICeuI,
an extra 15 bp in the pBAD promoter region (69) was added to form a hairpin
loop with the corresponding reverse complementary sequence on the I-CeuI
gene, effectively blocking gene expression and allowing synthesis. The I-CeuI
gene was subsequently cloned into the pJKR-H-TetR plasmid, a gift from
George Church (Addgene plasmid no. 62561) (23) to yield the chromosomal
degradation plasmid pJKR-HTetR-ICeuI (SI Appendix, Fig. S1B).
Culture Conditions for SimCells. For SimCell generation, strains containing the
pJKR-HTetR-ICeuI plasmid (SI Appendix, Fig. S1B) were induced with 100 nM
anhydrotetracycline (ATc), while strains with pRH121 were induced with
1 μM crystal violet. For SimCell verification, chromosomal expression of GFP
was induced with 0.2% arabinose. For protein production, strains containing
the pJKR-O-mphR plasmid (or a variation) were induced with 200 μM
erythromycin. For SimCell purification, a protocol was adapted from
Heinemann and Ankenbauer (33) using D-cycloserine to destroy parent cells.
Characterization of SimCell Populations. Flow cytometry analysis was done
with an S3e Cell Sorter (Bio-Rad). The FL1 filter was used to detect fluores-
cence fromGFP,which has an excitation/emission atwavelengths 488/507 nm.
The FL3 filter was used to detect fluorescence from mCherry, which has an
excitation/emission at 587/610 nm.
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Imaging. A Nikon Fluorescent Microscope Ti Eclipse (Nikon Ltd) was used to
take images and videos of bacterial cells. For videos, frames were taken every
15 min for about 24 h. Cells were first stained with 100 μM DAPI and then
fixed on an agar slide. The agar contained inducers for I-CeuI expression and
protein expression when appropriate.
Longevity of SimCells. Purified SimCell cultures expressing luminescence
(pJKR-OmphR-ilux) or an unstable mCherry variant (pJKR-OmphR-ASV) were
kept in 50 mL Falcon tubes shaking at 100 rpm at 37 °C. Every 2 d, 25 μg/mL
D-cycloserine was added to the cultures to maintain SimCell purity. At days
1, 3, 5, 10, 14, and 28, aliquots (200 μL, n = 4) were taken and measured for
luminescence or fluorescence production over 24 h. The maximum reading
during this period was recorded. OD600 was compared at t = 0 and t = 24 h
to see if there was an increase and therefore contamination by parent cells.
Proteomics and LC-MS/MS Analysis. Proteomics analysis was performed as
described previously (4). The proteomics data are available on MassIVE with
DOI 10.25345/C5HD3F.
Catechol Quantification Using LC. Samples were analyzed using LC (Agilent
1120 Compact). The metabolite separation was achieved using a ZORBAZ
Eclipse Plus C18 packed with 95 Å pore, 5 μm particle size, and 4.5 × 150 mm
column (Agilent). Elution was performed as previously described by Sawyer
and Kumar (70). For culture, 300 μL purified SimCells or parent cells in LB were
induced or not induced for catechol production in 1.5-mL Eppendorf tubes.
Tubes were placed in a shaking incubator overnight at 37 °C. Parent cells and
SimCells were spun down at 10,000 × g, and the supernatant was analyzed for
catechol concentration. OD600 was recorded to calculate the number of cells
per mL and subsequently the moles of catechol produced per cell.
Cell Viability Assay.Mammalian cells were seeded at a density of 1 × 104 cells
per well in 96-well tissue culture-treated plates and incubated for 24 h (n =
6). Supplements (catechol, SA, 25 μg/mL D-cycloserine, 105 SimCells) were
then added, and cells were incubated for another 24 h. In the case of Sim-
Cells, the inducer SA (or PBS) and D-cyloserine were added at the same time
to the mammalian cells. Cells were washed twice with PBS then fixed with
1% glutaraldehyde for 30 min. Cells were then stained with 0.5% crystal
violet solution for 1 h, washed, and resolubilized with 1% SDS and 10%
acetic acid. Absorbance was measured at 595 nm.
Modeling Energy Consumption in SimCells with the Glycolysis Pathway. In
SimCells which contain the glycolysis pathway, the overall energy E (molar) in
the form of ATP and NADH is used to drive protein production. The glycolysis
pathway (from glucose to pyruvate) is composed of ∼10 enzymatic reactions
operating in series. For simplicity, we considered the concentration of a
representative glycolytic enzyme, X. Its conservation can be modeled by the
following ordinary differential equation:
dX
dt
= rx1
E
E+Ke,x1
− Dx1X. [1]
The rate of glycolytic enzyme synthesis, rx1, has been proposed to hold a
simple Michaelis–Menten dependence on the intracellular energy level E.
The kinetic constant is Ke,x1. The rate of enzyme degradation is Dx1.
The change in the intracellular energy level (in forms of ATP and NADH) is
dictated by the energy production from glycolysis, energy consumption for
the transcription and translation of glycolytic enzymes, and energy
consumption for luminescence:
dE
dt
= re1X − ax1rx1
E
E +Ke,x1
− bE. [2]
The rate of energy production via glycolysis is re1. The energy demand per
unit rate of glycolytic enzyme synthesis is denoted by ax1. The rate of energy
consumption for luminescence is b. In this system, the substrate can deplete
over time, which could become a limiting factor for energy biogenesis.
Therefore, we link the rate of energy production ðre1Þ with the substrate
concentration S through the Michaelis–Menten kinetics:
re1 = re,max
S
S+Ks
. [3]
The maximum rate of energy production is re,max. The kinetic constant is Ks.
Subsequently, we introduce the dynamic change in the limiting substrate:
dS
dt
= −«re1X. [4]
The rate of substrate consumption is considered proportional to the rate of
energy production through a yield factor «.
Eqs. 1–4 are adopted as the key mechanisms underpinning the observed
variation in bioluminescence for a single cell system.
Please see SI Appendix for more detailed materials and methods.
Data Availability Statement. The proteomics data are available on MassIVE
with DOI 10.25345/C5HD3F.
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